Repurposed Drugs for Non-Melanoma Skin Cancer

This research investigates the efficacy of repurposed drugs in treating non-melanoma skin cancers, focusing on basal cell carcinoma and squamous cell carcinoma. We aim to identify relevant randomized controlled trials (RCTs), observational studies, and experimental research that explore the use of existing medications, originally intended for other conditions, in the treatment of non-melanoma skin cancers. The investigation seeks to uncover how these repurposed drugs affect tumor growth, patient survival rates, and recurrence, as well as any potential side effects or interactions. Key areas of interest include the pharmacological mechanisms of these drugs, their impact on cancer cell pathways, and their efficacy compared to standard treatments. Studies that examine genetic, molecular, and environmental factors influencing drug effectiveness in diverse populations are particularly relevant. The goal is to find evidence supporting new therapeutic strategies for non-melanoma skin cancers through drug repurposing.